Aims. The primary aim of this study was to assess the feasibility of recruiting and retaining patients to a patient-blinded randomized controlled trial comparing corticosteroid injection (CSI) to autologous protein solution (APS) injection for the treatment of subacromial shoulder pain in a community care setting. The study focused on recruitment rates and retention of participants throughout, and collected data on the interventions’ safety and efficacy. Methods. Participants were recruited from two community musculoskeletal treatment centres in the UK. Patients were eligible if aged 18 years or older, and had a clinical diagnosis of subacromial impingement syndrome which the treating clinician thought was suitable for treatment with a subacromial injection. Consenting patients were randomly allocated 1:1 to a patient-blinded subacromial injection of CSI (standard care) or APS. The primary outcome measures of this study relate to rates of recruitment, retention, and compliance with intervention and follow-up to determine feasibility. Secondary outcome measures relate to the safety and efficacy of the interventions. Results. A total of 53 patients were deemed eligible, and 50 patients (94%) recruited between April 2022 and October 2022. Overall, 49 patients (98%) complied with treatment. Outcome data were collected in 100% of participants at three months and 94% at six months. There were no significant adverse events. Both groups demonstrated improvement in patient-reported outcome measures over the six-month period. Conclusion. Our study shows that it is feasible to recruit to a patient-blinded randomized controlled trial comparing APS and CSI for subacromial pain in terms of clinical outcomes and health-resource use in the UK. Safety and efficacy data are presented. Cite this article: Bone Jt Open 2024;5(7):534–542

Aims. Astragalus polysaccharide (APS) participates in various processes, such as the enhancement of immunity and inhibition of tumours. APS can affect osteoporosis (OP) by regulating the osteogenic differentiation of human bone mesenchymal stem cells (hBMSCs). This study was designed to elucidate the mechanism of APS in hBMSC proliferation and osteoblast differentiation. Methods. Reverse transcriptase polymerase chain reaction (RT-PCR) and Western blotting were performed to determine the expression of microRNA (miR)-760 and ankyrin repeat and FYVE domain containing 1 (ANKFY1) in OP tissues and hBMSCs. Cell viability was measured using the Cell Counting Kit-8 assay. The expression of cyclin D1 and osteogenic marker genes (osteocalcin (OCN), alkaline phosphatase (ALP), and runt-related transcription factor 2 (RUNX2)) was evaluated using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). Mineral deposits were detected through Alizarin Red S staining. In addition, Western blotting was performed to detect the ANKFY1 protein levels following the regulation of miR-760. The relationship between miR-760 and ANKFY1 was determined using a luciferase reporter assay. Results. The expression of miR-760 was upregulated in OP tissues, whereas ANKFY1 expression was downregulated. APS stimulated the differentiation and proliferation of hBMSCs by: increasing their viability; upregulating the expression levels of cyclin D1, ALP, OCN, and RUNX2; and inducing osteoblast mineralization. Moreover, APS downregulated the expression of miR-760. Overexpression of miR-760 was found to inhibit the promotive effect of APS on hBMSC differentiation and proliferation, while knockdown of miR-760 had the opposite effect. ANKFY1 was found to be the direct target of miR-760. Additionally, ANKFY1 participated in the APS-mediated regulation of miR-760 function in hBMSCs. Conclusion. APS promotes the osteogenic differentiation and proliferation of hBMSCs. Moreover, APS alleviates the effects of OP by downregulating miR-760 and upregulating ANKFY1 expression. Cite this article: Bone Joint Res 2023;12(8):476–485

Introduction. Angiosarcomas are rare aggressive sarcomas of vascular endothelial origin. These tumours have the potential to be multicentric and are associated with high rates of local recurrence, which makes treatment challenging. The gold-standard is that these patients are managed in specialist centres by a multidisciplinary team. We present our experience of managing patients with angiosarcoma in the North of England Bone and Soft Tissue Tumour Service and a review of the literature. Methods. A prospectively collated electronic database was used to identify patients with angiosarcoma treated between 2000 and 2008, and an analysis performed of demographics, anatomical site, surgical excision and reconstruction, local disease recurrence and metastatic disease. Results. Fifteen patients (ten female, ?ve male, mean age 71 years) were identi?ed. Eight patients developed tumours in a previously irradiated area, after a mean of 11 years. Six patients had metastatic disease at presentation. Fourteen patients underwent wide surgical excision of the tumour, of which nine required defect reconstruction(?ve free latissimus dorsi ?aps, two free anterolateral thigh ?aps, two pedicled latissimus dorsi ?aps). One patient was treated with chemotherapy only. Five of 14 patients received adjuvant radiotherapy, and one received adjuvant chemotherapy. Two out of 14 patients developed local recurrence. Eight patients developed metastases, the majority of which were pulmonary. Estimated ?ve-year survival was calculated as 33% in our patient cohort. Conclusions. Angiosarcomas are aggressive, difficult to treat tumours, which can occur secondary to a multitude of causes. Clinical suspicion, biopsy and early diagnosis are essential to allow optimum treatment, which currently consists of radical surgery, together with adjuvant radiotherapy and chemotherapy

Aims

Orthopaedic surgery uses many varied instruments with high-speed, high-impact, thermal energy and sometimes heavy instruments, all of which potentially result in aerosolization of contaminated blood, tissue, and bone, raising concerns for clinicians’ health. This study quantifies the aerosol exposure by measuring the number and size distribution of the particles reaching the lead surgeon during key orthopaedic operations.

Introduction. Tibial components that match the resected proximal tibia may promote accurate rotational alignment and maximize coverage while minimizing overhang in total knee arthroplasty (TKA). Tibial component designs have traditionally been evaluated utilizing an overall anterior-posterior (AP)/medial-lateral (ML) ratio. However, since the tibial plateau is irregularly shaped, such a metric has drawbacks. Here, a detailed set of morphological metrics is used to evaluate six contemporary tibia designs against a multi-ethnic bone database. Methods. Tibial surfaces from 347 subjects, including 97 Indian (50m/47f), 99 Japanese (44m/55f), and 151 Caucasian (85m/66f), were virtually resected following a specific TKA procedure, as previous publications have shown surgical variability minimally impacts tibial resection morphology. Medial and lateral AP dimensions (MAP and LAP), ML width (ML), and medial and lateral anterior radii (MAR and LAR) were measured in a coordinate system constructed on the resected surface based on the neutral rotational axis (Fig. 1A). These metrics, along with anterior radius asymmetry (MAR/LAR), were regressed against ML for each ethnicity. The regressions were then compared with similar measurements obtained from tibial components in six contemporary TKA systems (one asymmetric: Design A; four symmetric: Designs B-E; and one anatomic: Design F). Results. The LAP of all six designs generally agrees well with the three ethnicities investigated. Designs A and F have MAP closer to tibial morphology (Fig. 2), while those of the symmetric designs are smaller than the morphological measurement, especially for tibiae with larger ML (Fig. 2). Across all three ethnicities, there is a positive correlation between anterior radii and ML (Fig. 3), which is reflected in each of the component designs. However, the symmetric designs tend to have bigger LAR and smaller MAR compared to the anatomic tibial morphology. Design F has the closest APs and anterior radii to the morphological measurements in all three ethnicities. The MAR/LAR is 1.8 ± 0.6 for Indian, 1.7 ± 0.4 for Caucasian, and 1.6 ± 0.3 for Japanese, and is negatively correlated with ML (Fig. 1B). However, except for Design F, which closely matches the measured morphology, all of the other designs investigated have constant and significantly lower MAR/LAR across all sizes (1 for the symmetric designs, 1.1 for the asymmetric design). Discussion. The ability to closely match the medial AP dimensions for Designs A and F suggests that anatomic or asymmetric designs with properly sized AP dimensions may reduce the amount of uncovered resected tibial surface compared to symmetric designs. Additionally, the current mismatch of the anterior radii in the asymmetric or symmetric component designs investigated may drive surgical compromise of coverage in order to facilitate rotational alignment or minimize overhang on the anterior regions of the resected tibia. Lastly, only the anatomic Design F accounts for the asymmetric characteristics of the tibial anterior radii, which may assist proper alignment of the tibial component, while the other five designs have either a radius ratio of 1 (Designs B-E) or a very small asymmetry (1.1, Design A). In summary, improved understanding of variations in tibial morphology across ethnicities can support continuous improvement of contemporary tibial component designs

Objectives

The accuracy and precision of two new methods of model-based radiostereometric analysis (RSA) were hypothesised to be superior to a plain radiograph method in the assessment of polyethylene (PE) wear.